If you click a social network icon and are not a looksneat user, you will be registered and you agree to looksneat's terms of service and privacy policy.Sign Up
Share Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
Request a feature